Mimedx (MDXG) Current Assets (2010 - 2026)

Mimedx (MDXG) has 17 years of Current Assets data on file, last reported at $240.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 20.1% year-over-year to $240.3 million; the trailing twelve-month figure through Mar 2026 stood at $240.3 million (up 20.1% YoY), and the FY2025 full-year result was $277.5 million, up 44.6% from the prior year.
• Current Assets declined to $240.3 million in Q1 2026, from $277.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $277.5 million in Q4 2025 to a low of $131.0 million in Q2 2022.
• A 5-year average of $175.2 million and a median of $154.5 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets decreased 11.3% in 2022 and jumped 47.61% in 2025, its largest moves.
• Tracing MDXG's Current Assets over 5 years: stood at $134.2 million in 2022, then increased by 22.4% to $164.3 million in 2023, then advanced by 16.82% to $191.9 million in 2024, then jumped by 44.6% to $277.5 million in 2025, then declined by 13.39% to $240.3 million in 2026.
• Business Quant data shows MDXG's Current Assets at $240.3 million in Q1 2026, $277.5 million in Q4 2025, and $254.1 million in Q3 2025.